United Health Group’s pharmacy benefit manager, Optum Rx, stopped covering Cole Schmidtknecht’s ‘life-changing’ inhaler, suit ...

Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...

The recent article detailing how President Donald Trump is reversing actions by the Biden administration that were working to bring down the high cost of prescription drugs resonated deeply with ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

But, that's as far as its gotten. The public has yet to see the benefits of paying lower costs for prescription drugs, including those to treat asthma, breast cancer, high blood pressure, type 2 ...

The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive growth. The number of Americans taking GLP-1s for weight loss rose more ...

“Only 18% of employers with 200+ employees are currently able to cover GLP-1s due to the high cost, even though approximately 35% to 45% of employees could be prescribed one of these medications.” ...